Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Aspire Biopharma Holdings Inc (NASDAQ: ASBP) closed the day trading at $0.58 down -21.62% from the previous closing price of $0.74. In other words, the price has decreased by -$21.62 from its previous closing price. On the day, 14.62 million shares were traded. ASBP stock price reached its highest trading level at $0.7535 during the session, while it also had its lowest trading level at $0.5313.
Ratios:
For a better understanding of ASBP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.01 and its Current Ratio is at 0.01. In the meantime, Its Debt-to-Equity ratio is 59.33 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASBP now has a Market Capitalization of 26643750 and an Enterprise Value of 257963360.
Stock Price History:
The Beta on a monthly basis for ASBP is 0.78, which has changed by -0.9472727 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, ASBP has reached a high of $15.80, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -93.07%, while the 200-Day Moving Average is calculated to be -94.48%.
Shares Statistics:
Over the past 3-months, ASBP traded about 192.41K shares per day on average, while over the past 10 days, ASBP traded about 1818810 shares per day. A total of 46.01M shares are outstanding, with a floating share count of 46.01M. Insiders hold about 0.00% of the company’s shares, while institutions hold 1.01% stake in the company.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
